Patient Power
CAR T-cell therapy can now be used for patients who have failed only one line of treatment for multiple myeloma. Abhinav Deol, M.D., hematologist, medical oncologist, and member of the Bone Marrow and Stem Cell Transplant, Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams, discussed safety when treating patients who have already been treated for myeloma and the studies that are ongoing.
Read the article here.